Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030016-005
Application #
7191318
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost

  Institution

Name
Bavarian Nordic A/S
Department
Type
DUNS #
City
State
Country
Zip Code

  Publications

Darsow, U; Sbornik, M; Rombold, S et al. (2016) Long-term safety of replication-defective smallpox vaccine (MVA-BN) in atopic eczema and allergic rhinitis. J Eur Acad Dermatol Venereol 30:1971-1977
von Sonnenburg, Frank; Perona, Pamela; Darsow, Ulf et al. (2014) Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis. Vaccine 32:5696-702
von Krempelhuber, Alfred; Vollmar, Jens; Pokorny, Rolf et al. (2010) A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. Vaccine 28:1209-16